Ganglion blockade by muscarine, oxotremorine and AHR-602.
D000818:Animals; D002415:Cats; D005071:Evoked Potentials; D005725:Ganglia, Autonomic / Q000187:drug effects / Q000502:physiology*; D005730:Ganglionic Blockers / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D013569:Synapses / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects*; D014203:Tremorine / Q000494:pharmacology*
D005730:Ganglionic Blockers; D010277:Parasympathomimetics; D011759:Pyrrolidines; D007545:Isoproterenol; D014203:Tremorine